Tuberculosis News and Research

Latest Tuberculosis News and Research

NIAID, Aeras partner for Phase II clinical trial of TB vaccine

Aeras announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate jointly developed by Aeras and Dutch biopharmaceutical company Crucell.

1 Feb 2012

$Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost$

Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost

Millions of poor Nigerians will gain access to the most effective combination treatment for malaria at a fraction of its current cost, following the successful conclusion of negotiations between the United Kingdom Department for International Development (DFID) funded Partnership for Transforming Health Systems (PATHS2) and a variety of international and national stakeholders in Nigeria this week.

31 Jan 2012

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.

31 Jan 2012

New general manager discusses future of Global Fund with Wall Street Journal

In an article examining recent developments at the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Wall Street Journal interviews Gabriel Jaramillo, the Colombian-born Brazilian citizen and former CEO of Sovereign Bank who will become the fund's new general manager this week.

31 Jan 2012

GRANITE program to aid in development of new TB fighting methods

A Rutgers-Camden professor is using his expertise in computer science to aid in the development of new methods to fight tuberculosis.

31 Jan 2012

Leprosy pathogen exploits micro-RNAs to weaken immune response

A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.

30 Jan 2012

International Roadmap for TB Research outlines priorities

In this post in the PLoS "Speaking of Medicine" blog, guest blogger Christian Lienhardt, senior scientific adviser at the Stop TB Partnership and WHO, "discusses the International Roadmap for Tuberculosis (TB) Research, a framework outlining priority areas for investment in TB research."

30 Jan 2012

Global Health Frontline News examines clean cookstove efforts in Tanzania

Global Health Frontline News (GHFN) reports on efforts to produce and provide clean cookstoves to people in Tanzania.

30 Jan 2012

Ban calls on business leaders to increase investment in women's education, health at WEF

Speaking at an event organized by the Every Woman Every Child initiative on Thursday, "Secretary-General Ban Ki-moon [called on] business leaders attending the World Economic Forum (WEF) in Davos, Switzerland, to increase their investment in women's education and health to ensure their well-being and encourage their participation in the world economy," the U.N. News Centre reports.

30 Jan 2012

Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

A new company formed around Michigan State University nanotechnology promises to move speedy detection of deadly pathogens and toxins from the laboratory directly to the field.

30 Jan 2012

Two initiatives launched at WEF with aim of ending new HIV infections among children by 2015

"Two groundbreaking initiatives, aimed at realistically achieving the once-unthinkable goal of ending new HIV infections among children by the end of 2015, were launched simultaneously at the World Economic Forum's Annual Conference in Davos" on Friday, according to a Business Leadership Council press release.

30 Jan 2012

Addressing TB prevention, treatment among migrant populations

In this post on USAID's "IMPACTblog," Christina Lau, USAID health officer for Central Asia, discusses tackling tuberculosis in migrant populations, writing, "Most migrants are unable to access the health care system because they are undocumented laborers, who lack proper identification documents required for health care treatment, and who fear deportation if their documentation status becomes known."

30 Jan 2012

Watching transformation of the Global Fund on its 10th anniversary

"Are we watching the rebirth of the troubled Global Fund to Fight Aids, Tuberculosis and Malaria, perhaps in a new, more U.S.-flavored guise?" Guardian health editor Sarah Boseley asks in her "Global Health Blog."

27 Jan 2012

Responding to emergence of drug-resistant tuberculosis

This post in the Center for Strategic and International Studies' "Smart Global Health" blog examines drug-resistant tuberculosis (TB), stating, "[S]ince the recent outbreak of the so-called totally drug-resistant tuberculosis (TDR-TB) in India, TB has a new face."

27 Jan 2012

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

"This week marks the 10th anniversary of the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria -- the world's most powerful tool for improving health -- at the World Economic Forum (WEF) in Davos, Switzerland," Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in this post in the AlertNet "Insight" blog.

27 Jan 2012

Gates pledges $750 million to Global Fund

Speaking at the World Economic Forum in Davos, Switzerland, on Thursday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, pledged $750 million on behalf of the foundation to the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, the Associated Press reports.

27 Jan 2012

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

In a speech to the European Parliament on Tuesday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "told European lawmakers in Brussels not to cut aid to poor countries despite the economic and budgetary problems facing" European Union (E.U.) countries, Agence France-Presse reports.

27 Jan 2012

First Edition: January 26, 2012

Today's health policy headlines include reports about House GOP plans to offer a 'replace' bill after the Supreme Court rules on the health law.

26 Jan 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

In the state of Jonglei in South Sudan, civilians continue to bear the brunt of inter-communal fighting. Wounded patients are still arriving at the Médecins Sans Frontières hospital in Pibor, three weeks after the violent attack on the town and outlying villages in Pibor County. Many were injured in the bush, where thousands have remained, afraid to come out of hiding. Médecins Sans Frontières medical teams are now treating serious wound infections, some several weeks old. Since re-launching emergency medical activities in Pibor on 7 January, Médecins Sans Frontières has treated 47 patients with gunshot wounds – 16 women and 8 children. A further 43 patients have so far been treated for stab wounds, beatings or wounds sustained while fleeing in the bush.

24 Jan 2012

Address drug resistant pathogens as part of 'next stage of global health'

This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."

24 Jan 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

NIAID, Aeras partner for Phase II clinical trial of TB vaccine

Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

New general manager discusses future of Global Fund with Wall Street Journal

GRANITE program to aid in development of new TB fighting methods

Leprosy pathogen exploits micro-RNAs to weaken immune response

International Roadmap for TB Research outlines priorities

Global Health Frontline News examines clean cookstove efforts in Tanzania

Ban calls on business leaders to increase investment in women's education, health at WEF

Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

Two initiatives launched at WEF with aim of ending new HIV infections among children by 2015

Addressing TB prevention, treatment among migrant populations

Watching transformation of the Global Fund on its 10th anniversary

Responding to emergence of drug-resistant tuberculosis

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

Gates pledges $750 million to Global Fund

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

First Edition: January 26, 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

Address drug resistant pathogens as part of 'next stage of global health'

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Tuberculosis News and Research

Latest Tuberculosis News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in